Azasite (azithromycin ophthalmic solution) 1%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Azasite (azithromycin ophthalmic solution) 1%, covering 2011-09-26 to 2011-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE) [Phase 4]